Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Digestive System

Gastrointestinal (GI) diseases affect the digestive tract—including the esophagus, stomach, intestines, and rectum—as well as accessory organs such as the liver, gallbladder, and pancreas. These conditions range from inflammatory and functional disorders to malignancies and metabolic liver diseases. Given the GI system’s central role in nutrient absorption, immunity, and microbiome-host interactions, research in this field supports improved therapeutic strategies and a deeper understanding of systemic health.

Tirzepatide Acetate(2023788-19-2 free base)
TP1111L
Tirzepatide (LY3298176) Acetate (2023788-19-2 free base) is a new molecule that can control blood glucose levels by combining dual agonism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.[3]
  • $358
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Docosahexaenoic Acid
DHA, Cervonic acid
T53696217-54-5
Docosahexaenoic Acid (DHA) is an essential omega-3 fatty acid prevalent in the brain and retina.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
ICG-001
T6113780757-88-2
ICG001 is a β-catenin/TCF-mediated transcription inhibitor that selectively blocks β-catenin/CBP interaction without interfering with β-catenin/p300 interaction. It specifically binds to CREB protein with an IC50 of 3 μM.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Ripretinib
DCC-2618
T84821442472-39-0
Ripretinib (DCC-2618) is an orally bioavailable inhibitor of (KIT) and (PDGFRA).
  • $68
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Balsalazide disodium dihydrate
T4615150399-21-6
Balsalazide sodium hydrate (Balsalazide disodium) is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.Balsalazide sodium hydrate is a new 5-aminosalicylic acid (5-ASA) containing prodrug. High dose Balsalazide sodium hydrate(3.0 g twice daily) was superior in maintaining remission in patients with ulcerative colitis compared with a low dose (1.5 g twice daily) or a standard dose of mesalazine (0.5 g three times daily). All three treatments were safe and well tolerated [1]. Balsalazide sodium hydrate is approved for the treatment of mild-to-moderate active UC. It is efficacious for the induction of remission in mild to moderate UC and has a favorable safety profile, with the added advantages of greater efficacy of remission induction and rapidity of onset [2].
  • $39
In Stock
Size
QTY
Corn oil
T51378001-30-7
Corn oil is a kind of vegetable oil extracted from corn germ. Corn oil is mainly used as a carrier and solvent in scientific research.
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Deruxtecan
T150981599440-13-7
Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker used in the synthesis of DS-8201 and U3-1402.
  • $44
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Etiprednol dicloacetate
BNP-166, BNP166, BNP 166
T31719199331-40-3In house
Etiprednol dicloacetate (BNP-166) is a corticosteroid with anti-inflammatory activity.Etiprednol dicloacetate inhibits the accumulation of eosinophils and can be used in the study of inflammatory airway diseases such as asthma and in the treatment of Crohn's disease.
  • $112
In Stock
Size
QTY
DC 07090
DC-07090, DC07090
T85337879070-72-1In house
DC 07090 is a human enterovirus 71 3C protease inhibitor with antiviral activity for the study of nucleic acid virus infections.
  • $195 TargetMol
In Stock
Size
QTY
Maralixibat Chloride
SHP-625 chloride, SHP625 chloride, SHP 625 chloride, LUM001 chloride, Lopixibat chloride, Livmarli chloride
T32873228113-66-4In house
Maralixibat Chloride (LUM001 chloride), an apical, sodium-dependent, bile acid transport inhibitor, prevents enterohepatic bile acid recirculation.
  • $263
In Stock
Size
QTY
Miricorilant
CORT-118335, CORT118335, CORT 118335
T333931400902-13-7In house
Miricorilant (CORT 118335) is a selective glucocorticoid receptor modulator for the study of digestive and metabolic disorders.
  • $293
In Stock
Size
QTY
Paeoniflorin
Peoniflorin
T223023180-57-6
Paeoniflorin (Peoniflorin) is a herbal constituent extracted from the root of Paeonia albiflora Pall.
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
Teduglutide
TAK633, TAK 633, Revestive, Gattex, ALX-0600, ALX0600
T35337197922-42-2
Teduglutide (ALX-0600) is a glucagon-like peptide-2 analog that increases intestinal absorption by promoting mucosal growth and reducing mucosal degradation, improving intestinal recovery. It is used in the study of short bowel syndrome (SBS). Teduglutide activates NR4a1/nur77 expression and FXR signaling, alleviating intestinal dysfunction in mice and improving lung injury, making it useful for studying metabolic and cardiovascular diseases.
  • $77
In Stock
Size
QTY
ZED-1227
ZED-101, TAK-227
T172891542132-88-6
ZED-1227 (TAK-227) is an orally active, selective and potent transglutaminase 2 (TG2) inhibitor with anticancer activity that blocks inflammation-induced TG2 expression and activation for the treatment of Celiac Disease.
  • $261
In Stock
Size
QTY
TargetMol | Citations Cited
7α-Hydroxy-4-cholesten-3-one
7-hydroxy-4-cholesten-3-one
T101963862-25-7
7α-Hydroxy-4-cholesten-3-one is an intermediate in bile acid synthesis from cholesterol, a PXR agonist, and a biomarker for bile acid loss and diseases related to defective bile acid biosynthesis. It is also the physiological substrate for [CYP8B1].
  • $289
In Stock
Size
QTY
LX-1031
T15796945976-76-1
LX-1031 is an effective inhibitor of tryptophan 5-hydroxylase. LX-1031 decreases serotonin (5-HT) synthesis peripherally.
  • $50
In Stock
Size
QTY
Infigratinib
NVP-BGJ398, BGJ-398
T1975872511-34-7
Infigratinib (NVP-BGJ398) (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and VEGFR2.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Pronase E (Activity ≥ 7000 U/g)
Pronase E, Pronase
T138279036-06-0
Pronase E is a proteolytic enzyme mixture obtained from Streptomyces griseus, which is capable of digesting proteins into individual amino acids.
  • $32
In Stock
Size
QTY
TargetMol | Citations Cited
Taurochenodeoxycholic Acid
TCDCA, Taurochenodeoxycholate, Chenyltaurine, Chenodeoxycholyltaurine, 12-Deoxycholyltaurine
T2A2481516-35-8
Taurochenodeoxycholic Acid (12-Deoxycholyltaurine) is one of the main bioactive substances of animals' bile acid.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Iberdomide
CC-220
T77911323403-33-3
Iberdomide (CC-220) is a modulator of cereblon( IC50 value of 60 nM in a competitive TR-FRET assay).
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Protoporphyrin IX
PPIX
T1192553-12-8
Protoporphyrin IX (PPIX) is a tetrapyrrole that is a metabolic precursor of heme, cytochrome c, and chlorophyll. Protoporphyrin IX has been shown to improve liver function, promote cellular tissue respiration, improve protein and glucose metabolism, and resist complement binding.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
Chlorophyllin sodium copper salt
Chlorophyllin coppered trisodium salt, Chlorophyllin copper sodium complex
T125411006-34-1
Chlorophyllin sodium copper salt (Chlorophyllin coppered trisodium salt) is a semi-synthetic mixture of water-soluble sodium copper salts derived from chlorophyll, primarily used as a food additive and alternative medicine.
  • $40
In Stock
Size
QTY
TargetMol | Citations Cited
Vedolizumab
T9914943609-66-3
Vedolizumab, a humanized monoclonal antibody, targets the α4β7 integrin for treating Crohn's disease and ulcerative colitis.
  • $198
In Stock
Size
QTY
Odevixibat
A4250
T16376501692-44-0
Odevixibat (A4250) is an effective, selective and orally active ileal bile acid transporter inhibitor. Odevixibat has the potential for the treatment of primary biliary cirrhosis. Odevixibat reduces cholestatic liver and bile duct injury in mice model.
  • $31
In Stock
Size
QTY